Onconetix, Inc. Common Stock
Symbol: ONCO (NASDAQ)
3.11
▼ (-3.27%) -0.105
Company Description:
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Key Stats
- Today's Open: $3.25
- Today's High: $3.29
- Today's Low: $2.96
- Today's Volume: 69.04K
- Yesterday Close: $3.21
- Yesterday High: $3.43
- Yesterday Low: $3.015
- Yesterday Volume: 159.68K
- Last Min Volume: 0
- Last Min High: $3.105
- Last Min Low: $3.105
- Last Min VWAP: $0
Company Profile
- Name: Onconetix, Inc. Common Stock
- Website: https://www.onconetix.com
- Listed Date: 2022-02-18
- Location: CINCINNATI, OH
- Market Status: Active
- CIK Number: 0001782107
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.96M
- Round Lot: 100
- Outstanding Shares: 1.55M
- Asset Type: CS
RECENT FILINGS FOR ONCO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | 8-K | View |
| 2025-09-22 | 8-K | View |
| 2025-09-04 | 8-K | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-16 | 4 | View |
| 2025-07-16 | SCHEDULE 13D/A | View |
| 2025-07-16 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 10-Q | View |
| 2025-06-11 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-06-02 | 10-K | View |
| 2025-05-22 | 8-K | View |
| 2025-05-02 | UPLOAD | View |
| 2025-04-30 | 8-K | View |
Latest News on ONCO